Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002042077-25-000006
Filing Date
2025-11-05
Accepted
2025-11-05 15:26:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4567
  Complete submission text file 0002042077-25-000006.txt   5959
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Subject) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93023 | Film No.: 251453565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6222 INDIANWOOD TR. BLOOMFIELD HILLS MI 48301
Business Address
Chernett Jorey (Filed by) CIK: 0002042077 (see all company filings)

Type: SCHEDULE 13G